Detalles de la búsqueda
1.
One-Year Brolucizumab Outcomes in Neovascular Age-Related Macular Degeneration from a Large United States Cohort in the IRIS® Registry.
Ophthalmology
; 130(9): 937-946, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37086857
2.
Factors Linked to Injection Interval Extension in Eyes with Wet Age-Related Macular Degeneration Switched to Brolucizumab.
Ophthalmology
; 130(8): 795-803, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36990322
3.
RETINAL VASCULITIS OR VASCULAR OCCLUSION AFTER BROLUCIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Systematic Review of Real-World Evidence.
Retina
; 43(7): 1051-1063, 2023 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36893438
4.
Impact of COVID-19 measures on exacerbation rates and healthcare visits in US asthma patients.
Allergy Asthma Proc
; 44(6): 422-428, 2023 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37919845
5.
Secukinumab's effect on structural damage progression in psoriatic arthritis: longitudinal mixture modelling of FUTURE-1 and FUTURE-5.
Clin Exp Rheumatol
; 39(5): 931-937, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33253089
6.
The "RCT augmentation": a novel simulation method to add patient heterogeneity into phase III trials.
BMC Med Res Methodol
; 18(1): 75, 2018 07 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29980181
7.
The "Efficacy-Effectiveness Gap": Historical Background and Current Conceptualization.
Value Health
; 19(1): 75-81, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26797239
8.
Real-World Safety Outcomes with Brolucizumab in Neovascular Age-Related Macular Degeneration: Findings from the IRIS® Registry.
Ophthalmol Ther
; 13(5): 1357-1368, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38520643
9.
The Treatment Patterns with Brolucizumab in Germany (REALIZE) Study: A Retrospective Cohort Study Based on Longitudinal Prescription Data.
Ophthalmol Ther
; 12(1): 195-208, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36327000
10.
Real-World Persistence and Treatment Interval in Patients with Diabetic Macular Edema Treated with Anti-Vascular Endothelial Growth Factors in the USA.
Ophthalmol Ther
; 12(5): 2465-2477, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37347405
11.
Short-Term Treatment Outcomes of Brolucizumab in Patients with Neovascular Age-Related Macular Degeneration: A Multicentre Indian Real-World Evidence Study.
Clin Ophthalmol
; 17: 2295-2307, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37583576
12.
Testing the "RCT augmentation" methodology: A trial simulation study to guide the broadening of trials eligibility criteria and inform on effectiveness.
Contemp Clin Trials Commun
; 33: 101142, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37397428
13.
Efficacy and safety of brolucizumab in age-related macular degeneration: A systematic review of real-world studies.
Acta Ophthalmol
; 101(2): 123-139, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36117281
14.
Real-World Frequency and Management of Ocular Adverse Events in Eyes with Neovascular Age-Related Macular Degeneration Treated with Brolucizumab.
Ophthalmol Ther
; 12(5): 2397-2408, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37310683
15.
Handling Missing Data in Health Economics and Outcomes Research (HEOR): A Systematic Review and Practical Recommendations.
Pharmacoeconomics
; 41(12): 1589-1601, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37490207
16.
Switching to brolucizumab: injection intervals and visual, anatomical and safety outcomes at 12 and 18 months in real-world eyes with neovascular age-related macular degeneration.
Int J Retina Vitreous
; 9(1): 8, 2023 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36726178
17.
One-Year and 18-Month Outcomes in nAMD Patient Eyes Switched to Brolucizumab Alone versus to Brolucizumab Alternating with Other Anti-VEGF Agents.
Clin Ophthalmol
; 17: 3601-3611, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38026599
18.
Anti-Vascular Endothelial Growth Factor Treatment Discontinuation and Interval in Neovascular Age-Related Macular Degeneration in the United States.
Am J Ophthalmol
; 242: 189-196, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35738393
19.
Comparative Efficacy of Brolucizumab in the Treatment of Neovascular Age-Related Macular Degeneration: A Systematic Literature Review and Network Meta-Analysis.
Adv Ther
; 39(8): 3425-3448, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35678996
20.
Proportion of Women and Reporting of Outcomes by Sex in Clinical Trials for Alzheimer Disease: A Systematic Review and Meta-analysis.
JAMA Netw Open
; 4(9): e2124124, 2021 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34515784